Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia

Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, View ORCID ProfileNikoloz Chkhartishvili
doi: https://doi.org/10.1101/2020.09.18.20195024
Tengiz Tsertsvadze
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
2Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lana Gatserelia
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marine Mirziashvili
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natia Dvali
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
3Caucasus International University, Tbilisi, Georgia
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akaki Abutidze
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
2Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
MD, MPH, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Revaz Metchurtchlishvili
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos el Rio
4Emory University, Atlanta, GA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikoloz Chkhartishvili
1Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
3Caucasus International University, Tbilisi, Georgia
MD, MS, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nikoloz Chkhartishvili
  • For correspondence: nc{at}aidscenter.ge
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

Data availability is restricted in accordance with national laws and regulations. Data are available from the Infectious Diseases, AIDS and Clinical Immunology Research Center for qualifying researchers. Data requests can be made at aids{at}aidscenter.ge.

Back to top
PreviousNext
Posted September 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, Nikoloz Chkhartishvili
medRxiv 2020.09.18.20195024; doi: https://doi.org/10.1101/2020.09.18.20195024
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos el Rio, Nikoloz Chkhartishvili
medRxiv 2020.09.18.20195024; doi: https://doi.org/10.1101/2020.09.18.20195024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)